Search Results
Found 33 results
510(k) Data Aggregation
(57 days)
Telford, Pennsylvania 18969
Re: K243606
Trade/Device Name: Babyroo TN300 Regulation Number: 21 CFR 880.5130
| 21 CFR §880.5130
- The subject, device and the predicate
device (K230278) are Class II devices regulated
under 880.5130
Under requlation 21 CFR 880.5130, both the subject Babyroo TN300 and the predicate Babyroo TN300 (K230278
and the predicate Babyroo TN300 device (K230278) have the same intended use under requlation 21 CFR 880.5130
The Babyroo TN300 is an open care radiant warmer that provides a controlled source of heat and regulation of skin temperature for neonates and infants. The optional integrated resuscitation module provides emergency respiratory support administered by clinicians and includes the functionality of suction. Additionally, the device provides weighing (optional) and pulse oximetry (optional) of neonates and infants. The device is designed for use with a body weight up to 10 kg (22 lb).
The device is indicated for thermoregulation, skin temperature regulation, weighing (optional), pulse oximetry (optional), and resuscitation (optional) of neonates and infants.
The purpose of this premarket notification is to activate, for the US market, existing optional functionality which enables the display of SpO2 information by the subject Babyroo TN300 via its graphical user interface (GUI). The SpO2 display functionality is facilitated through connection with existing, cleared pulse oximetry accessories which generate the SpO2 information that is displayed on the subject Babyroo TN300 GUI.
As originally cleared under K230278:
The Babyroo TN300 is an open care infant radiant warmer that provides controlled source heat and skin temperature display for use with neonates and infants. The device can be configured for either labor and delivery or the newborn intensive care unit (NICU) and can be used for intra hospital transfer. Warming therapy is interrupted during intra hospital transfer and patient is not supplied with heat.
The Babyroo TN300 device is offered with a fixed height or adjustable height trolley configuration and provides two heat sources for infant warming: a radiant warmer and an optional heating plate with conductive gel mattress. The device's bed can be tilted up to 15° in Trendelenburg and reverse Trendelenburg directions and the design of the device is intended to facilitate uniform heat distribution over the entire mattress surface across the range of bed tilt angulation. An optional removable canopy is available for intra-hospital transfer.
Infant warming is facilitated via three (3) available thermorequlation modes:
- Manual mode
- Skin temperature mode
- Kangaroo mode
The Babyroo TN300 is available with an optional Resuscitation module. The optional Resuscitation module is pneumatically powered, can be connected to central gas supplies or gas cylinders, and provides emergency resuscitation and suction to the patient. The optional Resuscitation module includes adjustment for gas flow, peak inspiratory pressure, O2 concentration, and suction functionality and is available in three (3) variants:
- Resuscitation module with gas mixer and AutoBreath®.
- Resuscitation module with gas mixer.
- Resuscitation with O2 only.
The optional AutoBreath® function facilitates pneumatically driven, automatic respiratory rate and positive end-expiratory pressure control.
The Babyroo TN300 can be configured to include an optional integrated electronic scale, as well as, optional heated gel mattress, optional integrated single or dual storage drawers, optional gas cylinder holders, and optional x-ray tray.
The provided text describes a 510(k) premarket notification for a modification to the Babyroo TN300 infant warmer device. The modification involves activating existing optional software functionality to display SpO2 information generated by existing, cleared pulse oximetry accessories. The core device functions for warming, resuscitation, and weighing remain unchanged from the predicate device (K230278).
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:
Key Takeaway: The submission focuses on demonstrating substantial equivalence for the new functionality (SpO2 display and associated alarms) by relying on existing clearances of the core device and the OEM pulse oximetry accessories, in conjunction with specific non-clinical verification testing of the integrated system. No new clinical studies were performed.
1. Table of Acceptance Criteria and Reported Device Performance
Since this is a 510(k) for a modification (enabling SpO2 display), the acceptance criteria primarily revolve around demonstrating that the new functionality performs as expected and does not introduce new safety or effectiveness concerns, especially concerning the integration with existing, cleared pulse oximetry technology. The performance is assessed by confirming conformity to relevant standards and effective data transfer.
Acceptance Criterion (for SpO2 display functionality) | Reported Device Performance (as per document) |
---|---|
Conformity to ISO 80601-2-61:2017 (Medical electrical equipment -Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment) | "Verification testing with respect to conformity to ISO 80601-2-61:2017 is included." and "Verification testing is included to demonstrate conformity of the subject device - in combination with the cleared OEM pulse oximetry accessories - to the FDA-recognized consensus standard relating to pulse oximetry." |
Effective Transfer of Pulse Oximetry Data (from OEM accessories to device display) | "Verification testing that confirms the effective transfer of the data generated by the OEM pulse oximetry devices is included in this premarket notification in support of substantial equivalence." and "OEM integration testing demonstrating the integrity of the SpO2 information generated by the cleared accessories and displayed by the subject Babyroo TN300 device is included." |
SpO2 Alarms Functionality (Upper/Lower SpO2, Desaturation, Pulse Rate) | The device "Facilitates the setting of SpO2 alarms for: - Upper limit for SpO2 - Lower limit for SpO2 - Lower alarm limit for desaturation - Upper alarm limit for pulse rate - Lower alarm limit for pulse rate." (Performance is implicitly accepted through the successful completion of ISO 80601-2-61:2017 conformity and data transfer testing, as these alarm functions are integral to pulse oximetry equipment.) |
Cybersecurity of External Interfaces (including SpO2 interface) | "Cybersecurity assessment of external interfaces, including the SpO2 interface, is included in support of substantial equivalence." and "Software Documentation: With reference to September, 2023, Guidance for Industry and Food and Drug Administration Staff: Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions." |
Overall Safety and Performance of the Modified Device | "The subject Babyroo TN300 was tested in accordance with applicable standards, guidance, and internal design requirements, including performance testing and functional/operation testing. Testing included the cleared OEM accessories that are relevant to the modification that is the subject of this premarket notification. The results of the non-clinical performance testing support substantial equivalence." This broadly covers the device's continued safe operation with the new feature integrated. |
2. Sample Size Used for the Test Set and Data Provenance
The document explicitly states: "No human clinical data are included in support of substantial equivalence." This means there isn't a "test set" in the traditional sense of patient data.
The testing relied on non-clinical performance testing:
- Sample Size: Not numerical. The testing involved the Babyroo TN300 device itself, presumably one or more units, integrated with the specific OEM Masimo SET® pulse oximetry accessories. The "sample" here refers to the actual device and integrated components under test in a laboratory/engineering setting.
- Data Provenance: The data comes from laboratory/engineering testing performed by the manufacturer (Draeger Medical Systems, Inc.). It is implicitly prospective in the sense that the testing was conducted specifically for this 510(k) submission to demonstrate the safety and effectiveness of the new functionality. No geographic origin for the test data is specified, but it would typically be conducted at the manufacturer's R&D facilities.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
Since no human clinical data or expert evaluations of images/readings were used for the test set (as this is a device modification for display of existing, cleared parameters), there were:
- Number of Experts: N/A.
- Qualifications of Experts: N/A.
The acceptance criteria were demonstrated through objective non-clinical performance testing against recognized standards (e.g., ISO 80601-2-61) and internal verification activities. The "ground truth" for the SpO2 display functionality would be the accurate and reliable transmission and display of the SpO2 and pulse rate data generated by the cleared OEM pulse oximetry accessories themselves, as validated in the OEM integration testing.
4. Adjudication Method for the Test Set
- Adjudication Method: N/A. As no human interpretation of data (e.g., images, vital signs patterns) was involved in a "test set" requiring ground truth establishment through expert consensus or adjudication, this is not applicable. The performance was verified through direct measurements and compliance with technical standards.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
- MRMC Study: No. The document explicitly states: "No human clinical data are included in support of substantial equivalence." This type of study is typically performed to evaluate diagnostic accuracy or human performance with AI assistance, neither of which is the primary focus of this specific device modification (which is display of a physiological parameter).
- Effect Size of Human Readers Improvement with AI vs Without AI Assistance: N/A, as no MRMC study was conducted.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study was Done
- Standalone Study: Yes, in a practical sense, the "OEM Integration Validation" is a form of standalone testing. This is described as validating "the effective transfer of pulse oximetry signals generated by a clinical simulator through the cleared OEM Masimo SET® pulse oximetry technology board to the subject Babyroo TN300 device's display." This tests the algorithm's ability (within the Babyroo TN300's software) to receive, process, and display the SpO2 data accurately from the source. The "algorithm" here isn't a complex diagnostic AI but rather the software logic for data handling and display.
7. The Type of Ground Truth Used
- Type of Ground Truth: The ground truth for validating the SpO2 display functionality was the known, simulated pulse oximetry signals generated by a "clinical simulator" and then interpreted by the already cleared OEM Masimo SET® pulse oximetry technology board. The test ensured that the Babyroo TN300 accurately displayed what the cleared OEM technology was reporting. Essentially, the ground truth was the output of the "cleared OEM Masimo SET® pulse oximetry technology," and the new device's display was compared directly to that expected output.
8. The Sample Size for the Training Set
- Training Set Sample Size: N/A. This device modification does not involve a machine learning or AI algorithm that requires a "training set" in the traditional sense. The software functionality being activated is to display existing, cleared data.
9. How the Ground Truth for the Training Set Was Established
- Ground Truth for Training Set: N/A, as no training set was used.
Ask a specific question about this device
(118 days)
Telford, Pennsylvania 18969
Re: K230278
Trade/Device Name: Babyroo TN300 Regulation Number: 21 CFR 880.5130
Class: | Babyroo TN300
Infant Radiant Warmer
Infant Radiant Warmer
21 CFR §880.5130
| 880.5130
Under regulation 21 CFR 880.5130, both the subject Babyroo TN300 and the predicate device (K120642) are
As requlated under 21 CFR 880.5130, the subject device has the identical intended use as the legally
The Babyroo TN300 is an open care radiant warmer that provides a controlled source of heat and regulation of skin temperature for neonates and infants. The optional integrated resuscitation module provides emergency respiratory support administered by clinicians and includes the functionality of suction. Additionally, the device provides weighing (optional) of neonates and infants. The device is designed for use with a body weight up to 10 kg (22 lb).
The device is indicated for thermoregulation, skin temperature regulation, weighing (optional), and resuscitation (optional) of neonates and infants.
The Babyroo TN300 is an open care infant radiant warmer that provides controlled source heat and skin temperature display for use with neonates and infants. The device can be configured for either labor and delivery or the newborn intensive care unit (NICU) and can be used for intra hospital transfer. Warming therapy is interrupted during intra hospital transfer and patient is not supplied with heat.
The Babyroo TN300 device is offered with a fixed height or adjustable height trolley configuration and provides two heat sources for infant warming: a radiant warmer and an optional heating plate with conductive gel mattress. The device's bed can be tilted up to 15° in Trendelenburg and reverse Trendelenburg directions and the design of the device is intended to facilitate uniform heat distribution over the entire mattress surface across the range of bed tilt angulation. An optional removable canopy is available for intra-hospital transfer.
Infant warming is facilitated via three (3) available thermoregulation modes:
- Manual mode
- Skin temperature mode
- Kangaroo mode
The Babyroo TN300 is available with an optional Resuscitation module. The optional Resuscitation module is pneumatic powered, can be connected to central gas supplies or gas cylinders and provides emergency resuscitation and suction to the patient. The optional Resuscitation module includes adjustment for gas flow, peak inspiratory pressure, O2 concentration, and suction functionality and is available in three (3) variants:
- Resuscitation module with gas mixer and AutoBreath®.
- Resuscitation module with gas mixer.
- Resuscitation with O2 only.
The optional AutoBreath® function facilitates pneumatically-driven, automatic respiratory rate and positive end-expiratory pressure control.
The Babyroo TN300 can be configured to include an optional integrated electronic scale, as well as, optional heated gel mattress, optional integrated single or dual storage drawers, optional gas cylinder holders, and optional x-ray tray.
The Babyroo TN300 device has an expected service life of 10 years.
The provided text is a 510(k) summary for the Dräger Babyroo TN300 infant radiant warmer. It details the device's indications for use, its comparison to a predicate device, and the non-clinical performance testing conducted to demonstrate substantial equivalence.
Here's an analysis of the provided information regarding acceptance criteria and the study that proves the device meets them:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not present a formal table of acceptance criteria with corresponding reported device performance values in a single, clear format as typically expected for specific performance metrics (e.g., a specific temperature range, with a specific accuracy requirement, and the measured accuracy).
Instead, the "7. Substantial Equivalence Comparison and Discussion" section (pages 6-7) serves as the de-facto presentation of performance characteristics and how they compare to the predicate device. For the characteristics where the proposed device differs, the "Comment" column often implies the acceptance criteria (i.e., that the performance meets safety and effectiveness requirements, even if different from the predicate).
Here's a partial reconstruction of a table based on the provided comparison, focusing on performance-related aspects and inferring acceptance criteria where possible:
Performance Characteristic | Acceptance Criteria (Inferred/Stated) | Reported Device Performance (Babyroo TN300) | Study that Proves Acceptance (Implied from text) |
---|---|---|---|
Body Weight Indication | Up to 10 kg (22 lb) | Up to 10 kg (22 lb) | Stated as identical to predicate, and established in contraindications. |
Irradiance (30% power) | 10 mW/cm² | 10 mW/cm² | Implied successful non-clinical performance testing against this specified value. |
Irradiance (60% power) | Not specified for predicate, accepted for proposed device. | 18 mW/cm² | Implied successful non-clinical performance testing. |
Irradiance (100% power) | Not specified for predicate, accepted for proposed device. | 32 mW/cm² | Implied successful non-clinical performance testing. |
Pre-warm Procedure | Same power sequence (100%, 60%, 30%) as predicate, with specified durations and alarms. | 100% for 3 min ("Pre"), 60% for 11.5 min ("Pre"), 30% ("30") until clinician sets value. Alarms at 14 min and shut off at 15 min if above 30%. | Implied successful non-clinical performance testing. |
Skin Temperature Mode | Set value control in 0.1 °C (0.1 °F) steps, range 34°C to 37°C, extended 37.1°C to 38°C. | Same as predicate. | Implied successful non-clinical performance testing. |
Kangaroo Warming Mode | Adequate warming by parent's body heat, device maintains 30% radiant warmer power, continuous patient temperature monitoring. | Patient warmed by parent's body heat; device switches to manual mode with 30% radiant warmer power; continuous patient temperature monitoring. | Verification of requirements relating to Kangaroo mode included in support of substantial equivalence (i.e., non-clinical performance testing). |
Skin Temperature Measurement Range | Inclusive of predicate (18°C to 43°C). | 13°C to 43°C (55.4°F to 109.4°F) | Implied successful non-clinical performance testing. |
Skin Temperature Measurement Accuracy | Comparable safety and effectiveness to predicate's ± 0.2°C display accuracy. | Overall Accuracy: ± 0.3°C (0.54°F) | Verification testing included in support of substantial equivalence (i.e., non-clinical performance testing). |
Skin Temperature Display Resolution | 0.1° | 0.1° | Implied successful non-clinical performance testing. |
Primary Patient Outlet Adjustable Airway Pressure Limit | Does not exceed predicate (50 cmH2O), typical 14 cmH2O (at 15 L/min) | Same as predicate. | Implied successful non-clinical performance testing. |
Suction Circuit Adjustable Suction Pressure | 0 kPa to 20 kPa (0 mmHg to 150 mmHg) | 0 kPa to 20 kPa (0 mmHg to 150 mmHg) | Implied successful non-clinical performance testing. |
Suction Circuit Maximum Flow Rate |
Ask a specific question about this device
(114 days)
53226
Re: K213551
Trade/Device Name: Giraffe Omnibed Carestation CS1 Regulation Number: 21 CFR 880.5130
The Giraffe OmniBed Carestation is a combination of an infant incubator and an infant warmer. The device can be operated as an incubator or as a warmer and can transition from one mode to the on user's demand. It cannot be operated in both modes at the same time. Incubators and warmers provide heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology.
Incubators provide an enclosed, temperature-controlled environment and warmers provide infrared heat in an open environment. They may also be used for short periods of time to facilitate the neonate's transition from the uterus to the external environment.
This device may incorporate a Servo Controlled Oxygen Delivery System. This is indicated to provide stable oxygen concentration within the infant compartment at the value set by the operator (21-65%).
The Giraffe Incubator Carestation is an enclosed infant bed, which provides thermal support for infants who are unable to provide for their own heat requirements. The device maintains the infant's temperature by circulating heated air within the closed bed compartment. The operator may select either the air or skin temperature control method. Depending on the control method selected, heat is regulated based on either the air temperature or the infant's skin temperature compared to the operator selected control temperature. Physical access to the patient is obtained through the side portholes or by opening one of the side doors. The Giraffe Incubator Carestation has a color touchscreen user interface (UI) and includes a Hands-Free Alarm Silence (HFAS) feature. The incubator includes a mattress for patient comfort. The Giraffe Incubator Carestation incorporates an optional weighing scale, Servo O2, Uninterruptible Power Supply (UPS) & Shuttle, Mounting Accessories Rail and Shelves and Storage drawers.
The provided document describes the Giraffe Incubator Carestation CS1, a medical device. The submission focuses on modifications to the porthole and wall latches of an existing predicate device (K152809). The document does not describe the device's main performance in terms of medical outcomes but rather the safety and functionality of the latch modifications.
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based solely on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly present a table of numerical acceptance criteria for the overall medical device performance (e.g., temperature control accuracy, humidity control). Instead, it focuses on demonstrating that the modified latch mechanisms continue to meet existing safety and performance standards, and that their functionality is equivalent or improved compared to the predicate without introducing new risks.
However, the document lists system performance specifications that are identical to the predicate device, implying these are the baseline acceptance criteria for the overall incubator function. For the latch modifications, the acceptance criteria are demonstrated through successful completion of various tests.
Acceptance Criteria (Implied from "Identical" or "Meets all performance and standards requirements") and Reported Performance for the General Device:
Characteristic | Acceptance Criteria (from Predicate Device K152809) | Reported Device Performance (Proposed Device) |
---|---|---|
Temp Control Accuracy | ± 1.0℃ (Control Temp vs. Avg. Incubator Temp) | Identical to Predicate |
Temp Variability | ± 0.5℃ (Incubator Temp vs. Avg. Incubator Temp) | Identical to Predicate |
Warm-up time | 12 hours | Identical to Predicate |
Porthole Latch Action | User action: Press to open. Push to close. | User action: Rotate to open. Turn to close. |
Wall Latch Function | Two latches, one latching point, pinch to open. | North side latches: Two latching points (primary and secondary), pinch to open. South side unchanged. |
Latch Functionality | Ensure proper securing of panels, allow operation, meet performance and standards (IEC 60601-2-19 Clause 201.9.8.3.101) | Meets all performance and standards requirements. |
Usability | No new risks or use-related issues. | No findings from summative usability testing that led to changes or new risks. |
2. Sample size used for the test set and the data provenance
The document describes non-clinical testing which includes various functional and reliability bench tests for the modified latches, as well as summative usability testing.
- Test Set Sample Size: The document does not specify a numerical sample size for the bench tests (e.g., number of latches tested, number of cycles for reliability). It lists the types of tests performed. For the "Summative Usability Testing," the sample size of participants is not provided.
- Data Provenance: The testing appears to be prospective and conducted by GE Healthcare (the submitter) in their own labs, as part of their quality system. The country of origin of the data is not explicitly stated but can be inferred to be internally generated by the manufacturer.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Number of Experts: Not specified for the bench tests. For the "Summative Usability Testing," the number of participants is not provided, and whether these participants are considered "experts" (e.g., clinicians) or typical end-users is not detailed.
- Qualifications of Experts: Not specified.
4. Adjudication method for the test set
Not applicable. This is not a study requiring adjudication of expert opinions (e.g., for image interpretation). The testing involves physical and functional evaluation against established standards and internal quality criteria. For usability, the findings are reported, implying evaluation against predefined usability metrics and safety outcomes.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This submission is for an infant incubator with modified latches, not an AI-powered diagnostic or interpretive device. Therefore, no MRMC study, human reader improvement, or AI assistance is relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not applicable. This device does not have an "algorithm only" component that would require standalone performance evaluation typical of AI/ML software.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
For the latch modifications, the "ground truth" is defined by:
- Compliance with Voluntary Standards: IEC 60601-1, IEC 60601-1-2, and IEC 60601-2-19.
- Engineering Specifications: Internal design requirements for load, torque, cycles, and physical dimensions that ensure safety and functionality.
- Risk Analysis: Identification and mitigation of potential risks associated with the changes.
- Usability Objectives: Ensuring the modified latches do not introduce new use errors or significantly alter the user experience negatively.
8. The sample size for the training set
- Not applicable. This device submission does not involve a "training set" in the context of machine learning or AI.
9. How the ground truth for the training set was established
- Not applicable. As there is no training set mentioned or relevant for this device, there is no ground truth established for one.
Ask a specific question about this device
(241 days)
53226
Re: K201628
Trade/Device Name: Panda iRes Warmer, Giraffe Warmer Regulation Number: 21 CFR 880.5130
|
| Regulation | 21 CFR 880.5130
Infant radiant warmers provide infrared heat in a controlled manner to neonates who are unable to thermoregulate based on their own physiology. Infant radiant warmers may be used to facilitate the neonate's transition to the external environment or to provide a controlled open environment. An optional integrated SpO2 monitoring feature may be used for continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (Sp02) and pulse rate (measured by a SpO2 sensor). An optional integrated resuscitation system may be used to provide the basic equipment required for pulmonary resuscitation of infants. Pulmonary resuscitation includes practices necessary to establish a clear airway and provide oxygen or air/oxygen mixtures and/or manual ventilation to the infant.
The Panda iRes Warmer and Giraffe Warmer are infant radiant warmers with a heating source intended to maintain the thermal balance of an infant patient by direct radiation of energy in the infrared region of the electromagnetic spectrum. This device also provides optional integrated SpO2 Monitoring and Resuscitation.
Radiant heat from an infrared heat source is focused onto the bed to warm the patient. The operator may select either the heater power or skin temperature control method. Depending on the control method selected, the heater is either regulated at the operator selected power level or the heater output is modulated to maintain the patient's temperature at the value selected by the operator.
The subject devices have two control modes, Manual Mode and Baby Mode. In the manual Mode, the warmer controls radiant heater output from a heater power percentage setting that you enter using the control panel. In baby mode, the warmer controls radiant heater output based on temperature readings from a probe attached to the baby's skin (skin temperature probe and the reflective probe patch) and a set temperature (set temp) you enter using the control panel.
This document describes the 510(k) summary for the Panda iRes Warmer and Giraffe Warmer, which are infant radiant warmers. The submission is for modifications to strengthen the bedside panels and latches.
Here's a breakdown of the requested information based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state acceptance criteria for each test in a numerical format that can be directly compared to reported device performance. Instead, it indicates that testing was "completed with passing results per the acceptance criteria defined in the test cases." The specific quantitative acceptance criteria are not provided in this summary.
Test Name | Reported Device Performance (as stated in document) |
---|---|
South Door Pull Test (includes Wall 20N IEC Push Test) | Test (completed with passing results) |
South Wall 660N Static Load Verification | Test (completed with passing results) |
Impact Test - Door shock frame test per IEC 60601-1 – 15.3.5.c. | Test (completed with passing results) |
Wall Threshold Test – Modified threshold test per IEC 60601-1 – | |
9.4.2.4.3 with operator pulling on wall instead of pushing on handle | Test (completed with passing results) |
East and West side panels are interchangeable | Analysis (completed with passing results) |
Wall Ergonomics – Caregiver Proximity | Analysis (completed with passing results) |
Panel Corner Spacing | Analysis (completed with passing results) |
Drawer Access | Analysis (completed with passing results) |
Side Wall Removal | Analysis (completed with passing results) |
Walls are Cleanable | 3rd Party Test (completed with passing results) |
Reliability - Wall Latch / Bed Pin Wear Test | Test (completed with passing results) |
Reliability - Wall Pull Fatigue Test | Test (completed with passing results) |
Reliability - Wall Lean Push Fatigue – Wall in Up Position | Analysis (completed with passing results) |
Reliability - Wall Knee Push Fatigue – Wall in Down Position | Test (completed with passing results) |
2. Sample Size Used for the Test Set and the Data Provenance
The document does not specify the sample sizes used for each test. The tests are described as "controlled engineering test fixtures" and "mathematical and statistical analyses," suggesting these were bench tests rather than tests on a specific patient or clinical dataset.
The data provenance is not explicitly stated in terms of country of origin or retrospective/prospective; however, the testing appears to be non-clinical performance and reliability testing conducted internally by GE Healthcare as part of their quality system.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
This information is not applicable. The testing described is non-clinical engineering and reliability testing of mechanical components. "Ground truth" in the context of clinical or diagnostic performance is not relevant here. The ground truth for these tests would be the established engineering specifications and regulatory standards (e.g., IEC 60601-1).
4. Adjudication Method for the Test Set
This information is not applicable as the tests are non-clinical engineering and reliability tests, not assessments that require human adjudication of a "ground truth" based on expert consensus.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, an MRMC comparative effectiveness study was not done. The document states, "The Panda iRes Warmer and Giraffe Warmer did not require clinical tests to support substantial equivalence." This submission is for modifications to a mechanical component (bedside panel and latches) of an existing device.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
This question is not applicable. The device is a physical medical device (infant radiant warmer) and not an AI algorithm. The testing focuses on the mechanical integrity and safety of the bedside panels and latches.
7. The Type of Ground Truth Used
The "ground truth" for the non-clinical testing appears to be based on:
- Engineering Specifications: Internal design requirements for the strength, durability, and functionality of the bedside panels and latches.
- Regulatory Standards: Compliance with relevant international standards such as AAMI / ANSI ES60601-1, AAMI / ANSI / IEC 60601-1-2, and IEC 60601-2-21, which define performance and safety criteria for medical electrical equipment and infant radiant warmers.
8. The Sample Size for the Training Set
This information is not applicable. There is no "training set" as this is a modification to a physical medical device and not an AI/ML algorithm development.
9. How the Ground Truth for the Training Set was Established
This information is not applicable for the reasons mentioned in point 8.
Ask a specific question about this device
(55 days)
HYDRO-TEMP Neonatal Skin Surface Temperature Sensor with Interface Cable Regulation Number: 21 CFR 880.5130
|
| Regulation Number: | 21 CFR 880.5130
The HYDRO-TEMP Neonatal Skin Surface Temperature Sensor is a non-sterile device intended for connection to an infant radiant warmer to monitor the neonatal patient's skin surface temperature.
The HYDRO-TEMP Neonatal Skin Surface Temperature Sensor consists of a probe used to monitor a neonate's skin surface temperature used as an accessory while the patient is on an infant radiant warmer. The probe is a wire set with a thermistor chip at the distal end that passively modifies the electrical current traveling through the device. A colored connector at the proximal end of the wire set interfaces with the warming bed or a cable that interfaces with the bed. The probe is packaged with an adhesive pad used to affix the sensor to the patient's skin surface. The device is non-sterile and individually packaged in a resealable plastic bag.
Based on the provided text, the device in question is the HYDRO-TEMP Neonatal Skin Surface Temperature Sensor.
Here's the breakdown of the acceptance criteria and study information:
1. Table of Acceptance Criteria and Reported Device Performance
Characteristic | Acceptance Criteria (Predicate Device) | Reported Device Performance (Subject Device) |
---|---|---|
Accuracy | ±0.2°C | ±0.2°C |
Sterility | Non-Sterile | Non-Sterile |
Biocompatibility | ISO 10993-1 compliant | ISO 10993-1 compliant |
Shelf Life | 3 years | 1 year (intent to extend to 5 years) |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the sample size used for the test set in terms of the number of individual devices or patients. It mentions that "All testing was performed on final, finished product manufactured with the proposed modification." However, it does not specify how many units constituted this "final, finished product."
Regarding data provenance, the document does not specify the country of origin of the data or whether the studies were retrospective or prospective.
3. Number of Experts Used to Establish Ground Truth and Qualifications
This information is not provided in the document. The studies performed are primarily technical performance tests.
4. Adjudication Method
This information is not applicable and not provided in the document, as the studies are technical performance tests rather than clinical evaluations requiring expert adjudication.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No. An MRMC comparative effectiveness study was not done. The device is a temperature sensor, and the studies performed are related to its technical performance and safety, not diagnostic interpretation by human readers.
6. Standalone Performance Study
Yes, standalone performance studies were done. The document states:
- "Accuracy testing was performed to IEC 60601-2-21 demonstrating the tolerance range of temperature readings with the proposed change."
- "Additionally, a time response test in accordance with ISO 80601-2-56 also was performed."
- "Evaluation and testing according to IEC 60601-1 and IEC 60601-1-2 also was performed to ensure the change to the thermistor encapsulation did not affect the electrical safety of the device."
- "The following biocompatibility tests were performed on the final, finished proposed device in accordance with ISO 10993 and FDA guidance: cytotoxicity, sensitization, and irritation."
These are all standalone tests evaluating the device's technical performance and safety characteristics.
7. Type of Ground Truth Used
The ground truth for the performance tests was based on established engineering standards and specifications:
- Accuracy: Reference to IEC 60601-2-21, implying comparison against a calibrated temperature standard.
- Time Response: Reference to ISO 80601-2-56, implying comparison against a defined response time standard.
- Biocompatibility: Reference to ISO 10993 and FDA guidance, ensuring compliance with established biological safety benchmarks.
- Electrical Safety: Reference to IEC 60601-1 and IEC 60601-1-2, ensuring compliance with established electrical safety standards.
8. Sample Size for the Training Set
This information is not applicable and not provided in the document. The device is a physical sensor, not an AI or machine learning algorithm that requires a training set.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable and not provided in the document. The device is a physical sensor, not an AI or machine learning algorithm that requires a training set and associated ground truth.
Ask a specific question about this device
(237 days)
Trade/Device Name: Hydro-Temp® Neonatal Skin Temperature Probe Cover Regulation Number: 21 CFR 880.5130
|
| Regulation Name: | 21 CFR 880.5130
The DeRoyal HYDRO-TEMP® Neonatal Skin Temperature Probe Covers are used to adhere the thermistor of the temperature probe to the patient and insulate the thermistor from ambient room temperature ensuring correct temperature readings.
The HYDRO-TEMP® Neonatal Skin Temperature Probe Cover is an accessory to be used with DeRoyal-branded NICU neonatal skin temperature probes used with an infant radiant warmer. They have not been evaluated for use with other manufacturer's products. It is an adhesive pad used to affix a temperature sensor to a neonate's skin to monitor the skin surface temperature. The cover also insulates the temperature sensor from ambient room temperature to ensure temperature readings are accurate.
There are two configurations of the probe cover. Both of these configurations contain a release liner, a patient-contacting hydrogel adhesive, and a metallized polyester backing. One configuration contains an additional foam material that is placed in between the hydrogel adhesive and metallic backing. The device is non-sterile and can be packaged on its own in a foil pouch or in a resealable plastic bag with a temperature probe.
The provided text describes the regulatory filing for the DeRoyal HYDRO-TEMP® Neonatal Skin Temperature Probe Cover (K191425) and its equivalence to a predicate device. The information is focused on mechanical and biocompatibility testing, rather than a clinical study evaluating the device's performance in terms of temperature reading accuracy.
Therefore, many of the requested categories related to clinical study design, such as sample size for test sets, data provenance, number of experts for ground truth, adjudication method, MRMC studies, and training set information, cannot be fully addressed from the provided document.
Here's a summary of the available information structured to answer your questions:
1. Table of Acceptance Criteria and Reported Device Performance
Acceptance Criteria / Test Performed | Reported Device Performance (HYDRO-TEMP® Neonatal Skin Temperature Probe Cover) | Predicate Device Performance (HYDRO-TEMP® NICU and Skin Surface Temperature Sensor (K925006)) |
---|---|---|
Average peel force per ASTM D903-98 | 4.42 N | 4.28 N |
Average force required to remove cover from surface (Internal Standard) | 10.1 N | 9.1 N |
Biocompatibility | ISO 10993-1 compliant (Cytotoxicity, Sensitization, Irritation) | ISO 10993-1 compliant |
Insulation Testing | Did not result in a temperature difference from the predicate device | Not explicitly stated, but implied as a baseline for comparison |
Accuracy Testing (IEC 60601-2-21) | Demonstrated the tolerance range of temperature readings when the probe cover was used | Not explicitly stated for the predicate in this context |
Note: The document states "The proposed device is similar to the predicate but with a modified hydrogel material to improve the adhesive strength, which is supported by performance testing." This implies the acceptance criterion for adhesive strength was to be at least equivalent to, if not better than, the predicate. The data shows it is better.
2. Sample size used for the test set and the data provenance
- Sample size: Not specified for any of the individual tests (peel force, pull test, insulation, accuracy, biocompatibility).
- Data provenance: The tests were conducted internally by DeRoyal Industries, Inc. (or contracted labs for biocompatibility) as part of their 510(k) submission. The data is retrospective for the purpose of demonstrating substantial equivalence to a legally marketed predicate device. Country of origin not explicitly stated, but DeRoyal is a U.S.-based company.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. This was not a clinical study involving human judgment or "ground truth" established by experts in the context of diagnoses or interpretations. The tests were objective mechanical and biological safety assessments.
4. Adjudication method for the test set
Not applicable. This was not a study requiring adjudication of expert opinions.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is a passive accessory (probe cover) and does not involve AI or human "readers" making interpretations.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This device is a physical medical accessory, not an algorithm.
7. The type of ground truth used
The "ground truth" for the performance tests would be the standardized testing methods themselves (e.g., ASTM D903-98 for peel strength, IEC 60601-2-21 for accuracy, ISO 10993 for biocompatibility) and the physical measurements obtained from those tests. There is no expert consensus, pathology, or outcomes data used as "ground truth" in the way it might be for a diagnostic device.
8. The sample size for the training set
Not applicable. This is not a machine learning or AI device that requires a training set.
9. How the ground truth for the training set was established
Not applicable.
Ask a specific question about this device
(276 days)
Austin, Texas 78754
Re: K173516
Trade/Device Name: NuBorne Infant Warmer Regulation Number: 21 CFR 880.5130
Identification:
Trade Name: NuBorne Infant Warmer Common Name: Radiant Warmer Regulatory Class: II Regulation: 880.5130
The NuBorne 500 Infant Warmer is an open care environment used for providing controlled infrared heat to neonates who are physiologically unable to maintain their body temperature or may require external heat to ease the transition from the mother's womb to the external environment.
The device is intended to be used in a Labor & Delivery environment for infants immediately after birth, or in a Neonatal Intensive Care Unit for providing premature infants long duration therapy, or in newborn care areas, for providing external heat to low-birth weight infants, and for cases where clinical indications require short/ long duration warming therapy.
The device allows access to the infants for various procedures, tilting of the infant and x-ray diagnostics. The device provides three modes of warming: Manual, Skin, and Standby mode for varying care requirements. Also, allows attaching optional accessories on the rail for therapy and monitoring of the infant.
The NuBorne Infant Warmer is an open care environment used for providing controlled infrared heat to neonates who are physiologically unable to maintain their body temperature or who need external heat to smoothen the transition from the mother's womb to the external environment.
The NuBorne Infant Warmer has three modes of temperature control available – manual temperature mode, skin temperature control mode and standby mode. The device includes a bed that tilts, has height adjustment, side panels, APGAR timer, x-ray tray and an optional inbed scale.
Here's a breakdown of the acceptance criteria and the study information for the NuBorne Infant Warmer, based on the provided text:
Important Note: The provided document is a 510(k) summary for a medical device, which focuses on demonstrating substantial equivalence to predicate devices rather than proving a device meets specific, predefined performance criteria through a traditional clinical study with human patients. As such, information regarding sample sizes, ground truth establishment for AI, human reader studies, and training sets (common in AI/software device submissions) is not applicable to this type of device and submission. This device is a hardware medical device, not an AI or software-as-a-medical-device.
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria here are derived from compliance to recognized medical device standards and functional performance compared to predicate devices. The "reported device performance" reflects how the NuBorne Infant Warmer meets these standards and compares to its predicates.
Acceptance Criterion (Standard/Characteristic) | Reported Device Performance (NuBorne Infant Warmer) |
---|---|
Indications for Use | Matches or is substantially equivalent to predicate devices (GE Medical Lullaby Warmer, Drager Medical Systems Babyleo TN500 - for warmer functions). Designed for neonates requiring controlled infrared heat for thermoregulation in L&D, NICU, and newborn care. |
Operating Modes (Skin Temp, Manual, Standby, Pre-Warm) | All modes (Skin Temp, Manual, Standby, Pre-Warm) are functional ("Yes"). Standby mode is standard. |
Operating Volume measured in patient bed | 36.2 dB(A) |
Alarm Volume | Adjustable from 54-69 dB(A) |
Power Failure Alarm | Continuous audible alarm when power switch is "On" and mains power is disconnected. Cannot be silenced. (Meets common safety practice). |
Air Temperature Measurement/Settings | Not measured as it's an open-air radiant warmer. (Consistent with predicate K121625). |
Oxygen Regulation | Does not regulate oxygen delivery; requires separate devices. (Consistent with predicate K121625). |
Radiant Warmer Settings Range in Manual Mode | Off-100% in 5% increments. Pre-Warm Mode: 100% for 10 minutes, then 50%. |
Radiant Warmer Skin Temperature Regulation Range | 34-38°C. Visual warning if setting >37°C. |
Skin Temperature Monitoring Range | 25-40°C |
Maximum Irradiance of Warmer | 25 mW/cm2 (at 100% power) |
APGAR Timer | Yes (0-60 minutes) |
Trending | Temperature and Weight |
Manual Mode Setting Range | 0 to 100% in 5% increments |
Set Temperature Range | 33 to 38 °C (in 0.1 increments) |
Heater Hood Swivel | Two Sides |
Integrated X-Ray Cassette Tray | Yes |
Bed Tilt Mechanism | Continuous up to 12° |
Storage Drawer Available | Yes |
Access Panels | All side panels are hinged for patient access. |
Castors | 4 double castors with locking brakes. |
Weighing Scale | 250g - 10kg (optional accessory) |
High Priority Alarms | High skin temp, Low skin temp, Check Baby, Max temp, Skin temp probe disconnected, Skin temp probe failure. |
Medium/Low Priority Alarms | N/A (Unlike K162821 which has several specific medium priority alarms) |
Power Supply | 115V – 230V, 50/60 Hz |
Power Consumption | 750W |
Weight (without options/accessories) | 105kg |
Height (mm) | 1800 – 2000 |
Width (mm) | 850 |
Length (mm) | 1170 |
Mattress Height from Floor (mm) | 900-1100 |
Mattress Size (mm) | 450 x 650 |
Material Used for Indirect Patient Contact | Metal (e.g., Aluminum); Molded Plastic |
Material Used for Direct Patient Contact | Cell Cast Acrylic; Textile (Wiman) |
Bisphenol A (BPA) | BPA free in-patient compartment |
Latex | Latex Free |
IEC 60601-1 (General Safety for Medical Electrical Equipment) | Pass |
IEC 60601-1-2 (EMC) | Pass |
IEC 60601-1-6 (Usability) | Pass |
IEC 60601-1-8 (Alarm Systems) | Pass |
IEC 60601-1-10 (Physiological Closed-Loop Controllers) | Pass |
IEC 60601-2-21 (Infant Radiant Warmers Specific) | Pass |
Software Verification & Validation Testing | Conducted and documentation provided as recommended by FDA. |
Device Validation (Functional Performance) | Tested to confirm performance to essential requirements: warming, skin temperature monitoring, alarms. |
Biocompatibility Testing | Conducted per ISO-10993 (Cytotoxicity, Irritation, Sensitization). |
Human Factor Evaluation | Conducted per FDA guidance. |
Reprocessing Evaluation | Conducted per FDA guidance. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size for Test Set: Not applicable. This is a hardware medical device, not an AI/software device that uses a "test set" of data in the sense of classification or diagnostic performance. Performance was evaluated through bench testing and compliance with standards.
- Data Provenance: Not applicable. The "data" here refers to direct measurements and observations during engineering and safety testing of the device itself, rather than patient data.
3. Number of Experts Used to Establish Ground Truth and Qualifications
- Number of Experts: Not applicable. The "ground truth" for a hardware device like an infant warmer is established through engineering specifications, regulatory standards, and physical measurements (e.g., temperature accuracy, noise levels, safety features). This does not typically involve expert radiologists or similar medical specialists establishing a "ground truth" for classification tasks.
- Qualifications of Experts: N/A for establishing "ground truth" in this context. However, engineering and regulatory experts would have overseen the testing and documentation.
4. Adjudication Method for the Test Set
- Adjudication Method: Not applicable. This is a hardware device; thus, there is no "test set" that requires adjudication by human readers for diagnostic or classification concordance.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- MRMC Study: No. This type of study is relevant for diagnostic imaging devices or AI-powered clinical decision support systems where human reader performance is being evaluated with and without AI assistance. The NuBorne Infant Warmer is a therapeutic/supportive care device.
- Effect Size: Not applicable.
6. Standalone Performance Study (Algorithm Only)
- Standalone Performance Study: No. This concept is for AI algorithms. The NuBorne Infant Warmer is a physical device with embedded software controlling its functions, but it's not an "algorithm only" device in the sense implying standalone diagnostic or predictive performance. Its performance is its standalone performance as a medical device.
7. Type of Ground Truth Used
- Type of Ground Truth: For this device, the "ground truth" is defined by:
- Engineering Specifications: Designed parameters and tolerances for temperature, noise, physical dimensions, etc.
- International and National Medical Device Standards (e.g., IEC 60601 series): These standards define acceptable safety, electrical, mechanical, and performance characteristics.
- Internal Validation and Verification Protocols: Procedures to confirm the device operates according to its design and specifications.
- Biocompatibility Standards (ISO-10993): Defining acceptable biological response of materials.
8. Sample Size for the Training Set
- Sample Size for Training Set: Not applicable. This device does not use machine learning or AI that requires a "training set" of data.
9. How the Ground Truth for the Training Set Was Established
- Ground Truth for Training Set Establishment: Not applicable, as there is no training set for this device type.
Ask a specific question about this device
(259 days)
| 21 CFR 880.5130
Babyleo TN500 is intended for use with premature babies and can be used as both an incubator and a radiant warmer. When the product is switched between incubator and radiant warmer operation, patients continue to be kept warm during the transition. The device provides a thermally regulated environment for patients with a body weight of up to 5 kg (11 lbs) and a height of up to 55 cm (22 in). The device can be operated as either a closed care unit or an open care unit. As a closed care unit, Babyleo TN500 is an incubator.Neonates are kept warm in the patient with humidifiable air, which can be enriched with oxygen (option). As an open care unit, Babyleo TN500 is a radiant warmer. Babyleo TN500 provides controlled ambient conditions for premature babies and neonates. The following parameters are regulated, according to the intended use: - Temperature - Humidity - Oxygen (option)
The device Babyleo TN500 is a medical device used to maintain environmental conditions suitable for preterm babies and neonates. The important features are temperature and humidity. The operational principle is a combination of a neonatal incubator and an open warmer.
Babyleo TN500 can be operated in closed care therapy as an incubator according to IEC60601-2-19 or in open care therapy as a warmer according to IEC60601-2-21. Additionally, an optional x-ray translucent heated mattress is intended to provide sensible heat to the preterm babies and neonates.
The device consists of the following components: Incubator (=bassinet) with a convection heater and closed humidification system for the patient, trolley, radiant warmer, display, mattress, x-ray and height adjustment. Optional components are scale, heated mattress, drawer, oxygen regulation with cylinder holder and Auto Thermo package and Developmental Care package.
This document is a 510(k) Premarket Notification for the Babyleo TN500, a neonatal incubator and radiant warmer. It aims to demonstrate substantial equivalence to legally marketed predicate devices. The information provided heavily focuses on design verification and validation testing, and therefore, does not contain the details on acceptance criteria and study proving performance in the context of an AI/ML medical device that would typically involve clinical studies, multi-reader multi-case studies, and explicit ground truth establishment with expert consensus.
Given the document talks about a physical medical device (neonatal incubator/radiant warmer) and not an AI/ML diagnostic or prognostic tool, the questions posed about "acceptance criteria and the study that proves the device meets the acceptance criteria" in terms of clinical performance metrics like sensitivity, specificity, or AUC, multi-reader multi-case studies, expert consensus for ground truth, effect size for human reader improvement with AI assistance, and training/test set sample sizes and provenance for AI/ML models are not applicable to this submission.
The "acceptance criteria" and "study that proves the device meets the acceptance criteria" for this conventional medical device primarily revolve around safety and performance standards, electrical safety, EMC, software verification, biocompatibility, human factors, and reprocessing validation.
Here's how to address the prompt based on the provided document:
1. A table of acceptance criteria and the reported device performance:
The document lists compliance with various standards and provides specifications that serve as performance criteria.
Acceptance Criteria (Standard Compliance / Performance Spec) | Reported Device Performance (Compliance / Value) |
---|---|
Electrical Safety: IEC 60601-1, IEC 60601-2-19, IEC 60601-2-21, IEC 60601-2-35 | Device complies with all listed standards. |
Electromagnetic Compatibility (EMC): IEC 60601-1-2 | Device complies with the standard. |
Software Verification and Validation: FDA Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." (2005) | Software verification and validation testing conducted; documentation provided; considered "major" level of concern. |
Biocompatibility: ISO 10993, ISO 10993-1, ISO 10993-17, ISO 10993-18 | Evaluation conducted in accordance with FDA guidance; battery of testing included: Integral Test for volatile organic compounds, Photogenic bacteria test, Emission of particles, Material characterization, Toxicological Evaluation, Cytotoxicity, Irritation, Sensitization. |
Human Factors: FDA Guidance: Applying Human Factors and Usability Engineering to Medical Devices Guidance for Industry and Food and Drug Administration Staff, 2016 | Usability evaluation conducted in accordance with FDA guidance. |
Reprocessing: FDA Guidance: Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling; Guidance for Industry and Food and Drug Administration Staff, 2015 | Reprocessing validation conducted in accordance with FDA guidance. |
Operating Noise Volume in Patient Compartment | Typically 40 dB(A) (Measured without oxygen application) - _(Compared to predicate |
Ask a specific question about this device
(104 days)
Common/Usual Name:
Infant Warmer
Classification Names: Warmer, Infant Radiant
Product Code: FMT 880.5130
Maryland 20723
Re: K123309
Trade/Device Name: Giraffe and Panda Warmers Regulation Number: 21 CFR 880.5130
Infant radiant warmers provide infrared heat in a controlled manner to neonates who are unable to thermo-regulate based on their own physiology. Infant radiant warmers may be used to facilitate the neonate's transition to the external environment or to provide a controlled open environment. An optional integrated SpO2 monitoring feature may be used for continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor). An optional integrated resuscitation system may be used to provide the basic equipment required for pulmonary resuscitation of infants. Pulmonary resuscitation includes practices necessary to establish a clear airway and provide oxygen or air/oxygen mixtures and/or manual ventilation to the infant.
The Giraffe and Panda Warmers are devices with a radiant heating source intended to maintain the thermal balance of an infant patient by direct radiation of energy in the infrared region of the electromagnetic spectrum. The warmers operate similarly to warmers currently in use in hospitals. Radiant heat from an infrared heat source is focused onto the bed to warm the patient. The operator may select either the heater power or skin temperature control method. Depending on the control method selected, the heater is either regulated at the operator selected power level or the heater output is modulated to maintain the patient's temperature at the value selected by the operator. Infant radiant warmers are also used to provide thermal support during surgical procedures and during procedures such as extracorporeal membrane oxygenation, resuscitation, or other procedures requiring open access and thermal support. The units also feature optional integrated SpO2 and Resuscitation modules. The Resuscitation Module may feature either a traditional bag-and-mask technology or a T-piece technology. Both the SpO2 module and the Resuscitation Modules use existing technology. The Giraffe and Panda Warmers can be used with the Giraffe Shuttle and UPS, a mobile power source that allows for transport of the patient between care areas within the hospital building and provides power to the Warmers.
The provided GE Healthcare 510(k) Premarket Notification Submission (K123309) describes modifications to existing Giraffe and Panda Warmers, specifically introducing Freestanding and Wall Mount configurations. However, the document explicitly states that clinical studies were not required to support substantial equivalence for these modifications. Therefore, the submission does not contain information about acceptance criteria or a study proving the device meets them in the context of clinical performance or diagnostic efficacy.
The submission focuses on engineering verification and validation (non-clinical tests) to demonstrate that the modified warmers maintain the same safety and effectiveness as the predicate devices.
Here's a breakdown of the requested information based on the provided text, highlighting what is available and what is explicitly not available or applicable:
-
A table of acceptance criteria and the reported device performance
No such table is provided in the document for clinical performance. The document describes several non-clinical quality assurance measures and testing but does not detail specific acceptance criteria or performance metrics in a table format for clinical use.
-
Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
Not applicable. The document states: "The subject of this premarket submission... did not require clinical studies to support substantial equivalence." Therefore, there was no clinical test set with a specific sample size or data provenance.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. As no clinical studies were performed, there was no ground truth to establish for a clinical test set by experts.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. As no clinical studies were performed, there was no test set requiring adjudication.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is an infant radiant warmer, not an AI-assisted diagnostic tool for human readers. No MRMC study was performed.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable in the context of diagnostic AI. The device features an "patient temperature control algorithm previously cleared per 510(k) K090697." The software changes involved scaling heater power and adopting this existing proportional heater control algorithm. The performance of this control algorithm was likely validated during the original 510(k) for the Giraffe and Panda Warmer (K090697) through engineering tests, but not as a "standalone diagnostic algorithm."
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not applicable for clinical ground truth. For the engineering validation of the device (non-clinical tests), the ground truth largely relies on compliance with voluntary standards, design specifications, and safety requirements (e.g., surface touch temperatures at maximum altitude, maximum ambient operating temperature, bed surface height).
-
The sample size for the training set
Not applicable. As no AI/machine learning model for clinical/diagnostic use is being described, there is no training set in that context. The "software changes" mentioned relate to control algorithms for heater power, which are typically derived from engineering principles and validated through testing, not "trained" on data in the AI sense.
-
How the ground truth for the training set was established
Not applicable, as there is no training set in the AI/machine learning context described in this document.
Summary of Non-Clinical Tests (from the document):
The device underwent the following non-clinical tests to demonstrate substantial equivalence:
- Risk Analysis
- Design Reviews
- Testing on unit level (Module verification)
- Integration testing (System verification)
- Performance testing (Verification)
- Safety testing (Verification)
- Simulated use testing (Validation)
These tests evaluate the device's compliance with engineering specifications, safety standards, and functional performance, but they are not clinical studies designed to establish diagnostic accuracy or compare human reader performance. The main purpose of this 510(k) was to introduce new mechanical configurations and minor software adjustments to an already cleared device, without changing its fundamental technology or indications for use.
Ask a specific question about this device
(245 days)
Regulation Number: Product Code: Class:
Manufacturer Name and Address:
Infant Radiant Warmer 21 CRF 880.5130
|
| Regulation Number | 880.5130
| 880.5130
November 2, 2012
Re: K120642
Trade/Device Name: Resuscitaire Radiant Warmer Regulation Number: 21 CFR 880.5130
The Resuscitaire® Radiant Warmer is intended for thermoregulation, skin temperature monitoring, APGAR timing and resuscitation of newly born infants up to 10kg. It is not intended for long term resuscitation or home use.
The modified Resuscitaire Radiant Warmer is for newbom infants and consists of a bassinet, warmer and a controller module which provides heat control, monitoring of the skin temperature and an APGAR timer. It also includes optional manual and automated resuscitation with suction and oxygen delivery and a patient gas supply breathing circuit.
The provided document is a 510(k) summary for a medical device called the "Resuscitaire Radiant Warmer." This type of document is for premarket notification of a device claiming substantial equivalence to a legally marketed predicate device, not typically for evaluating AI/algorithm performance. Therefore, much of the requested information, specifically regarding AI algorithm performance, ground truth, sample sizes for training/test sets, expert adjudication methods, and MRMC studies, is not applicable to this type of traditional medical device submission.
The "study" described in this document is a comparison of technological characteristics with predicate devices and non-clinical testing to demonstrate safety and effectiveness for a modified device.
Here's a breakdown of the requested information based on the provided text:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly present acceptance criteria in a quantitative table with corresponding device performance metrics in the typical format for AI/algorithm performance studies. Instead, it compares specifications and performance characteristics of the device under review (Resuscitaire Radiant Warmer with AutoBreath feature) against three predicate devices. The "reported device performance" is implied by demonstrating substantial equivalence across these characteristics.
Based on the "Comparison of Technological Characteristics with Predicate Devices" table, here's an attempt to structure relevant points into the requested format, focusing on the added AutoBreath™ Infant Resuscitator Feature (AB) as it represents the primary modification and subject of comparative analysis. It's important to note that the "acceptance criteria" here are essentially the characteristics of the predicate devices or established medical norms.
Acceptance Criteria (Based on Predicate Devices/Medical Norms) | Reported Device Performance (Resuscitaire Radiant Warmer with AutoBreath-AB) | Comments from Document |
---|---|---|
I:E Ratio: Within normal range for neonatal ventilation (e.g., 1:1 to 1:3). Predicate MVP-10: 1:8 to 3:1 (adjustable). Predicate Neopuff: Manually estimated. | Fixed internally at 1:2 nominal (1:1.6 to 1:2.2) (non-adjustable). | "The fixed I:E ratio of the AB falls within the normal range for neonatal ventilation as published in the Assisted Ventilation of the Neonate 4th Edition copyright 2003, (1:1 to 1:3). Additionally the 2010 AHA Guidelines for neonatal resuscitation recommend breath rates of 40 -60 BPM. All three devices can provide I:E ratios within the recommended range. The Neopuff is manually estimated and controlled by the user therefore both the I:E ratio and BPM will vary. The preset I:E ratio of the RW82 w/ AB eliminates human variation by guaranteeing a consistent I:E ratio." |
Adjustable PEEP: Minimum 3-4 cmH2O for newborns, flow rate 5-8 LPM for low birth weight, 6-10 LPM for term infants. Predicate MVP-10: Variable up to 18 ± 3 cm H2O. Predicate Neopuff: 1-25 cm H2O/mbar across different LPMs. | @ 5 LPM minimum PEEP 14 cm H2O. | "Although not identical, the PEEP ranges are similar. Based on the application of use the differences are not significant. For newborns the recommendations are: minimum PEEP from 3 to 4 cmH2O, and flow rate 5 to 8 LPM for low birth weight infants and flow rate 6 to 10 LPM for term infants." |
Adjustable Respiratory Rate Range: Predicate MVP-10: 0 to 120 BPM. Predicate Neopuff: User dependent. | 18 to 60 BPM ± 10% of setting. | "Both the RW82 w/ AB and the MVP10 allow the user to set the respiratory rate. The advantage of a set respiratory rate is to eliminate the human variation associated with manually controlled rates (RW82 & Neopuff). The MVP10 has a larger respiratory rate range, is due to the patient population of the MVP10 which includes pediatrics. The RW82 w/ AB is only intended for the resuscitation of newborns in L&D environments." |
Adjustable Airway Pressure Relief (PIP): Predicate MVP-10: 10 + 5 to 80 + 10 cm H2O. Predicate Neopuff: 2 to 80 cm H2O. | 0 to 50 cmH2O + 5 cm H2O (0 to 4.9 kPa + 0.5 kPa). | "The MVP10 and the Neopuff have a larger range based on patient populations for ventilation, while RW82 w/ AB is only intended for the resuscitation of newborns in L&D environments." |
Fixed Max Pressure (P Lim min): Predicate MVP-10: Variable up to 70 ± 10 cm H2O. Predicate Neopuff: Variable up to 80 cm H2O. | 50 cm H2O + 10% (5.0 kPa + 10%). | "The differences between the fixed max pressures of the MVP-10, Neopuff & Auto-Breath are related to the environment in which resuscitation is provided... Like the Neopuff, the RW82 w/ AB also provides manually adjustable PEEP & PIP. It differs in that it provides a lower fixed max. pressure because the intended use is limited to the L&D." |
Fixed Min Pressure (P Lim min): Predicate RW82: 0 cmH2O. Predicate MVP-10: 0 cmH2O. Predicate Neopuff: 0 cm H2O ± 2. | Same as predicate RW82 (0 cmH2O). | None specified beyond "Same as predicate RW82". This indicates it meets or is equivalent to the predicate. |
Logic Circuit (Pneumatic Control): Predicate MVP-10: Approx 4 LPM at 50 BPM. Predicate Neopuff: None. | 5 LPM (for pneumatic control for AutoBreath). | "Like the MVP-10 the RW82 w/ AB is a pneumatically controlled device. Both circuits control the time intervals between exhalation and inspiration and the pressure in the patient circuit." |
Dead Space: Predicate MVP-10: 0.5 ml max. Predicate Neopuff: 6 ml. | 3.4 ml. | "Dead space will vary based on the make up/mfg. of the patient breathing circuit." |
Body Weight Range: Predicate MVP-10: Applications requiring TV up 660 ml. Predicate Neopuff: Up to 10 kg. | Same as Neopuff (up to 10 kg). | This indicates it meets or is equivalent to the predicate. |
Patient Interface: Predicate MVP-10: Endotracheal Tube. Predicate Neopuff: Face Mask or Endotracheal Tube. | Face Mask. | None. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Sample Size: Not applicable. This device is a hardware product with added functionality, not an AI/algorithm. The "testing" referred to is engineering verification and validation, as well as comparison of specifications to predicate devices.
- Data Provenance: Not applicable.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- Not applicable. This is not an AI/algorithm being evaluated for diagnostic or prognostic accuracy against a ground truth established by experts. The "ground truth" for this device's performance is its physical and functional specifications.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not applicable.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This is not an AI-assisted device requiring an MRMC study.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not applicable. The AutoBreath feature is an integrated pneumatic control system, not a standalone algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- Not applicable in the context of an AI/algorithm's "ground truth." For this device, the "ground truth" for its performance evaluation (non-clinical testing) refers to established engineering standards, guidance documents (e.g., ISO, AAMI/ANSI), and the performance characteristics of its predicate devices, as well as physiological recommendations for neonatal resuscitation (e.g., AHA Guidelines for neonatal resuscitation).
8. The sample size for the training set
- Not applicable. There is no training set for this type of device.
9. How the ground truth for the training set was established
- Not applicable.
Ask a specific question about this device
Page 1 of 4